Inhalant Use Disorder

Inhalant use disorder is a psychiatric condition that applies to the deliberate use of inhalants, not to the accidental inhalation of toxic or psychoactive substances, even if they are the same substances that are people inhale when they have inhalant use disorder, and even if they produce identical effects.


Cluster Number:
Wiki Number: W105
Diagnosis: Inhalant Use Disorder
US Patients: 38 of 50 states make sales of inhalants illegal below age 18
World Patients:
Sex Ratio:
Age Onset: 10-12 years, can be fatal
Brain Area: Individual uses can lower oxygen levels & affect heart rhythms; regular use, harm to brain, heart, kidneys and liver
Symptoms: chemicals whose vapors can be breathed in for intoxication; “sniffing, huffing or bagging”; solvents, gases, medical drugs
Progression: By type: petroleum products, gases, medical anesthetics; abuses vary by product; pregnant users may injure fetuses.
Causes: Hostility to accepted cultural norms
Medications: None listed.
Therapies: None listed.


The world-wide medical research
reports chosen for each diagnosis 

Clicking each title opens the
PubMed article’s summary-abstract.

  • Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease 'OFF' episodes
    by Andrew Thach on January 24, 2022

    Aim: To compare efficacy of apomorphine sublingual film (APL) and levodopa inhalation powder (CVT-301) for 'on-demand' treatment of Parkinson's disease 'OFF' episodes. Patients & methods: Patient-level data from an APL pivotal study were re-weighted to match average baseline characteristics from a CVT-301 study (SPAN-PD). Placebo-adjusted treatments were compared at week 12. Results: Improvements in predose Unified Parkinson's Disease Rating Scale Part III scores were significantly larger for...

  • How do we manage asthma? Assessment of knowledge, attitude, and practice patterns among pulmonologists and allergists
    by Fatma Esra Günaydın on January 24, 2022

    Objective: The objective of this study was to evaluate and compare knowledge, attitude, and practice patterns between pulmonologists and allergists for adult asthma in Turkey.Methods: Questionnaire-based data were gathered from pulmonologists (236) and allergists (62), who had been members of the Turkish Thoracic Society and Turkish National Society of Allergy and Clinical Immunology in January-March 2021. Univariate and multivariate statistics were used to determine the factors associated with...

  • Effects of Perioperative Epidural Analgesia on Cancer Recurrence and Survival
    by Donghang Zhang on January 24, 2022

    Surgical resection is the main curative avenue for various cancers. Unfortunately, cancer recurrence following surgery is commonly seen, and typically results in refractory disease and death. Currently, there is no consensus whether perioperative epidural analgesia (EA), including intraoperative and postoperative epidural analgesia, is beneficial or harmful on cancer recurrence and survival. Although controversial, mounting evidence from both clinical and animal studies have reported...

  • Isolation and Identification of a Rare Spike Gene Double-Deletion SARS-CoV-2 Variant From the Patient With High Cycle Threshold Value
    by Li-Teh Liu on January 24, 2022

    Coronavirus disease 2019 (COVID-19) is an emerging life-threatening pulmonary disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan, Hubei Province, China, in December 2019. COVID-19 develops after close contact via inhalation of respiratory droplets containing SARS-CoV-2 during talking, coughing, or sneezing by asymptomatic, presymptomatic, and symptomatic carriers. This virus evolved over time, and numerous genetic variants...